# FDA Inspection 1307194 - Give Legacy - March 10, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/give-legacy/da2ded9d-d92b-4473-a5b2-dc2c5b1a3e39
Source feed: FDA_Inspections

> FDA Inspection 1307194 for Give Legacy on March 10, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1307194
- Company Name: Give Legacy
- Inspection Date: 2026-03-10
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1305512 - 2026-02-27](https://www.globalkeysolutions.net/records/fda_inspections/give-legacy/9179a8ad-85d8-4f5c-9ab9-ee9ab9c8dee5)
- [FDA Inspection 1158848 - 2021-12-01](https://www.globalkeysolutions.net/records/fda_inspections/give-legacy/647a9414-582a-4c83-be58-eba2a5625a87)
- [FDA Inspection 1158848 - 2021-12-01](https://www.globalkeysolutions.net/records/fda_inspections/give-legacy/9fac57a7-8970-4205-b444-cec6daf40c63)
- [FDA Inspection 1158848 - 2021-12-01](https://www.globalkeysolutions.net/records/fda_inspections/give-legacy/ed90b415-0c18-40cf-8c17-dcbca889005f)

Company: https://www.globalkeysolutions.net/companies/give-legacy/4dbaf2e3-e94c-45b0-a7fc-7686ed733f88

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d